Literature DB >> 25161935

Presence of thyroid-associated ophthalmopathy in Hashimoto's thyroiditis.

Emrah Kan1, Elif Kilic Kan2, Gülcin Ecemis3, Ramis Colak2.   

Abstract

AIM: To determine the prevalence of ophthalmopathy in Hashimoto's patients and to make a comparison in subgroups of patients.
METHODS: The study involved 110 Hashimoto's thyroiditis patients and 50 control subjects attending to the endocrinology department of the hospital. Subgroup classification of patients was made as euthyroid, subclinic and clinic in Hashimato's thyroiditis. All patients were evaluated by a single experienced ophthalmologist for the prevalence and characteristics of eye signs.
RESULTS: The overall prevalences of eye changes were 22.7% (25 patients) in patients and 4% (2 persons) in control subjects respectively (P=0.002). In patients the most common symptom was retrobulbar eye pain with or without any eye movement. Thirteen patients had significant upper eyelid retraction (11.8%). Six patients had eye muscle dysfunction as reduced eye movements in up gaze. In control patients one person had proptosis and another had lid retraction. The clinical activity score and classification of the ophthalmopathy did not show any significant differences among subgroups.
CONCLUSION: The eye signs were mostly mild (22.7%) and the most common eye sign was the presence of upper eyelid retraction (11.8%). Additionally six patients had eye muscle dysfunction as reduced eye movements in up gaze. Therefore we recommend to make a routine ophthalmic examination in Hashimoto's thyroiditis patients in order not to omit the associated ophthalmopathy.

Entities:  

Keywords:  Graves' ophthalmopathy; Hashimoto's thyroiditis; thyroid-associated ophthalmopathy; upper eyelid retraction

Year:  2014        PMID: 25161935      PMCID: PMC4137199          DOI: 10.3980/j.issn.2222-3959.2014.04.10

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  21 in total

Review 1.  Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management.

Authors:  M Yamada; A W Li; J R Wall
Journal:  Crit Rev Clin Lab Sci       Date:  2000-12       Impact factor: 6.250

Review 2.  Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease.

Authors:  Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

3.  Classification of the eye changes of Graves' disease.

Authors:  W M Wiersinga; M F Prummel; M P Mourits; L Koornneef; H R Buller
Journal:  Thyroid       Date:  1991       Impact factor: 6.568

4.  Isolated Inferior rectus muscle myopathy due to Hashimoto's thyroiditis.

Authors:  Akiyuki Hiraga; Masahiro Mimura; Ikuo Kamitsukasa
Journal:  Intern Med       Date:  2008-07-01       Impact factor: 1.271

Review 5.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

6.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Authors:  M P Mourits; M F Prummel; W M Wiersinga; L Koornneef
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

7.  Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?

Authors:  Bamini Gopinath; Leon Wescombe; Bao Nguyen; Jack R Wall
Journal:  Orbit       Date:  2009

8.  Pathogenesis of thyroid-associated ophthalmopathy: an autoimmune disorder of the eye muscle associated with Graves' hyperthyroidism and Hashimoto's thyroiditis.

Authors:  J R Wall; N Bernard; A Boucher; M Salvi; Z G Zhang; J Kennerdell; A Tyutyunikov; C Genovese
Journal:  Clin Immunol Immunopathol       Date:  1993-07

9.  The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event.

Authors:  Leon Wescombe; Hooshang Lahooti; Bamini Gopinath; Jack R Wall
Journal:  Clin Endocrinol (Oxf)       Date:  2010-10       Impact factor: 3.478

Review 10.  Thyroid associated orbitopathy.

Authors:  Rajat Maheshwari; Ezekiel Weis
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848

View more
  4 in total

Review 1.  Pain in optic neuropathies.

Authors:  Stefania Bianchi Marzoli; Alessandra Criscuoli
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 2.  "Orbiting around" the orbital myositis: clinical features, differential diagnosis and therapy.

Authors:  F Montagnese; S Wenninger; B Schoser
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

Review 3.  Diplopia in a patient with Hashimoto's thyroiditis: A case report and literature review.

Authors:  Chengqun Ju; Linna Zhang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

4.  Cavernous Sinus Dural Arteriovenous Fistula in a Patient with Thyroid-Associated Ophthalmopathy: Complete Resolution after Medical Treatment.

Authors:  Nicola Cavasin; Fabio Presotto; Matteo Bellamio; Enrico Cagliari
Journal:  Brain Sci       Date:  2021-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.